Ral small GTPase signaling and oncogenesis: More than just 15 minutes of fame |
| |
| Institution: | 1. University of North Carolina at Chapel Hill, Department of Pharmacology, Chapel Hill, NC, USA;2. Department of Genetics, Harvard Medical School, Boston, MA, USA;3. University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA;4. Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA |
| |
| Abstract: | Since their discovery in 1986, Ral (Ras-like) GTPases have emerged as critical regulators of diverse cellular functions. Ral-selective guanine nucleotide exchange factors (RalGEFs) function as downstream effectors of the Ras oncoprotein, and the RalGEF–Ral signaling network comprises the third best characterized effector of Ras-dependent human oncogenesis. Because of this, Ral GTPases as well as their effectors are being explored as possible therapeutic targets in the treatment of RAS mutant cancer. The two Ral isoforms, RalA and RalB, interact with a variety of downstream effectors and have been found to play key and distinct roles in both normal and neoplastic cell physiology including regulation of vesicular trafficking, migration and invasion, tumor formation, metastasis, and gene expression. In this review we provide an overview of Ral biochemistry and biology, and we highlight recent discoveries. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
